Precision Medicine Approach Based on Molecular Alterations for Patients with Relapsed or Refractory Multiple Myeloma: Results from the MM-EP1 Study.

Saved in:
Bibliographic Details
Title: Precision Medicine Approach Based on Molecular Alterations for Patients with Relapsed or Refractory Multiple Myeloma: Results from the MM-EP1 Study.
Authors: Andreozzi F; Département d'Innovation Thérapeutique et d'Essais Précoces, Gustave Roussy, 94805 Villejuif, France.; Hematology Department, Institute Jules Bordet, 1070 Bruxelles, Belgium., Dragani M; Hematology Department, Gustave Roussy, 94805 Villejuif, France., Quivoron C; Translational Research Hematological Laboratory, Gustave Roussy, 94805 Villejuif, France.; INSERM U1170, Université Paris-Saclay, Gustave Roussy, 94805 Villejuif, France., Le Bras F; Hematology Department, Assistance Publique Hôpitaux de Paris, Hôpital Henri Mondor, 94000 Créteil, France., Assi T; Hematology Department, Gustave Roussy, 94805 Villejuif, France., Danu A; Hematology Department, Gustave Roussy, 94805 Villejuif, France., Belhadj K; Hematology Department, Assistance Publique Hôpitaux de Paris, Hôpital Henri Mondor, 94000 Créteil, France., Lazarovici J; Hematology Department, Gustave Roussy, 94805 Villejuif, France., Cotteret S; Department of Medical Biology and Pathology, Gustave Roussy, 94805 Villejuif, France., Bernard OA; INSERM U1170, Université Paris-Saclay, Gustave Roussy, 94805 Villejuif, France., Ribrag V; Département d'Innovation Thérapeutique et d'Essais Précoces, Gustave Roussy, 94805 Villejuif, France.; Hematology Department, Gustave Roussy, 94805 Villejuif, France.; Translational Research Hematological Laboratory, Gustave Roussy, 94805 Villejuif, France.; INSERM U1170, Université Paris-Saclay, Gustave Roussy, 94805 Villejuif, France., Michot JM; Département d'Innovation Thérapeutique et d'Essais Précoces, Gustave Roussy, 94805 Villejuif, France.; Hematology Department, Gustave Roussy, 94805 Villejuif, France.; INSERM U1170, Université Paris-Saclay, Gustave Roussy, 94805 Villejuif, France.
Source: Cancers [Cancers (Basel)] 2023 Feb 28; Vol. 15 (5). Date of Electronic Publication: 2023 Feb 28.
Publication Type: Journal Article
Journal Info: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 36900299
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Precision Medicine Approach Based on Molecular Alterations for Patients with Relapsed or Refractory Multiple Myeloma: Results from the MM-EP1 Study.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Andreozzi+F%22">Andreozzi F</searchLink>; Département d'Innovation Thérapeutique et d'Essais Précoces, Gustave Roussy, 94805 Villejuif, France.; Hematology Department, Institute Jules Bordet, 1070 Bruxelles, Belgium.<br /><searchLink fieldCode="AU" term="%22Dragani+M%22">Dragani M</searchLink>; Hematology Department, Gustave Roussy, 94805 Villejuif, France.<br /><searchLink fieldCode="AU" term="%22Quivoron+C%22">Quivoron C</searchLink>; Translational Research Hematological Laboratory, Gustave Roussy, 94805 Villejuif, France.; INSERM U1170, Université Paris-Saclay, Gustave Roussy, 94805 Villejuif, France.<br /><searchLink fieldCode="AU" term="%22Le+Bras+F%22">Le Bras F</searchLink>; Hematology Department, Assistance Publique Hôpitaux de Paris, Hôpital Henri Mondor, 94000 Créteil, France.<br /><searchLink fieldCode="AU" term="%22Assi+T%22">Assi T</searchLink>; Hematology Department, Gustave Roussy, 94805 Villejuif, France.<br /><searchLink fieldCode="AU" term="%22Danu+A%22">Danu A</searchLink>; Hematology Department, Gustave Roussy, 94805 Villejuif, France.<br /><searchLink fieldCode="AU" term="%22Belhadj+K%22">Belhadj K</searchLink>; Hematology Department, Assistance Publique Hôpitaux de Paris, Hôpital Henri Mondor, 94000 Créteil, France.<br /><searchLink fieldCode="AU" term="%22Lazarovici+J%22">Lazarovici J</searchLink>; Hematology Department, Gustave Roussy, 94805 Villejuif, France.<br /><searchLink fieldCode="AU" term="%22Cotteret+S%22">Cotteret S</searchLink>; Department of Medical Biology and Pathology, Gustave Roussy, 94805 Villejuif, France.<br /><searchLink fieldCode="AU" term="%22Bernard+OA%22">Bernard OA</searchLink>; INSERM U1170, Université Paris-Saclay, Gustave Roussy, 94805 Villejuif, France.<br /><searchLink fieldCode="AU" term="%22Ribrag+V%22">Ribrag V</searchLink>; Département d'Innovation Thérapeutique et d'Essais Précoces, Gustave Roussy, 94805 Villejuif, France.; Hematology Department, Gustave Roussy, 94805 Villejuif, France.; Translational Research Hematological Laboratory, Gustave Roussy, 94805 Villejuif, France.; INSERM U1170, Université Paris-Saclay, Gustave Roussy, 94805 Villejuif, France.<br /><searchLink fieldCode="AU" term="%22Michot+JM%22">Michot JM</searchLink>; Département d'Innovation Thérapeutique et d'Essais Précoces, Gustave Roussy, 94805 Villejuif, France.; Hematology Department, Gustave Roussy, 94805 Villejuif, France.; INSERM U1170, Université Paris-Saclay, Gustave Roussy, 94805 Villejuif, France.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101526829%22">Cancers</searchLink> [Cancers (Basel)] 2023 Feb 28; Vol. 15 (5). <i>Date of Electronic Publication: </i>2023 Feb 28.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22MDPI%22">MDPI </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101526829 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>2072-6694 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220726694%22">20726694 </searchLink><i>NLM ISO Abbreviation: </i>Cancers (Basel) <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36900299
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3390/cancers15051508
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Precision Medicine Approach Based on Molecular Alterations for Patients with Relapsed or Refractory Multiple Myeloma: Results from the MM-EP1 Study.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Andreozzi F
      – PersonEntity:
          Name:
            NameFull: Dragani M
      – PersonEntity:
          Name:
            NameFull: Quivoron C
      – PersonEntity:
          Name:
            NameFull: Le Bras F
      – PersonEntity:
          Name:
            NameFull: Assi T
      – PersonEntity:
          Name:
            NameFull: Danu A
      – PersonEntity:
          Name:
            NameFull: Belhadj K
      – PersonEntity:
          Name:
            NameFull: Lazarovici J
      – PersonEntity:
          Name:
            NameFull: Cotteret S
      – PersonEntity:
          Name:
            NameFull: Bernard OA
      – PersonEntity:
          Name:
            NameFull: Ribrag V
      – PersonEntity:
          Name:
            NameFull: Michot JM
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 28
              M: 02
              Text: 2023 Feb 28
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-print
              Value: 2072-6694
          Numbering:
            – Type: volume
              Value: 15
            – Type: issue
              Value: 5
          Titles:
            – TitleFull: Cancers
              Type: main
ResultId 1